Metal organic frameworks for the catalytic detoxification of chemical warfare nerve agents

Patent metadata

Field	Value
Publication number	US-10272279-B2
Application number	US-201715412412-A
Country	US
Kind code	B2
Filing date	Jan 23, 2017
Priority date	Dec 31, 2013
Publication date	Apr 30, 2019
Grant date	Apr 30, 2019

Abstract

A method of using a metal organic framework (MOF) comprising a metal ion and an at least bidendate organic ligand to catalytically detoxify chemical warfare nerve agents including exposing the metal-organic-framework (MOF) to the chemical warfare nerve agent and catalytically decomposing the nerve agent with the MOF.

First claim

What is claimed is:

1. A method of using a metal organic framework (MOF) comprising a metal ion and an at least bidendate organic ligand to catalytically detoxify chemical warfare nerve agents comprising:
exposing the MOF to the chemical warfare nerve agent; and
catalytically decomposing the nerve agent with the MOF,
wherein metal nodes of the MOF comprise derivatives of:
Ti x Zr y Hf z (μ 3 -O) r , where x+y+z=6 and r=4, 6 or 8,

wherein the metal nodes of the MOF comprise:
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (H 2 O) 6 (OH) 6 (O 2 ) 6 or Ti x Zr y Hf z (μ 3 -O) 8 (O 2 ) 6 and where the oxygen atoms from the organic linker are included in the formula and where x+y+z=6; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (O L ) 24 where x+y+z=6, m=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (OH) l X m (H 2 O) n (O L ) 16 where x+y+z=6, n=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (RCOO) 6 (O L ) 12 where x+y+z=6, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (OH) l X m (H 2 O) n (O L ) 12 where x+y+z=6, n=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=6; where X is any anion with a −1 charge.

2. A method of using a metal organic framework (MOF) comprising a metal ion and an at least bidendate organic ligand to catalytically detoxify chemical warfare nerve agents comprising:
exposing the MOF to the chemical warfare nerve agent; and
catalytically decomposing the nerve agent with the MOF,
wherein metal nodes of the MOF comprise derivatives of:
Ti x Zr y Hf z (μ 3 -O), where x+y+z=6 and r=4, 6 or 8,
wherein the chemical warfare nerve agent is an organophosphate, an organophosphorus compound, or combinations thereof.

3. The method of claim 1 , wherein the nerve agent comprises cyanogen chloride, hydrogen cyanide, ethyldichloroarsine (ED), methyldichloroarsine (MD), phenyldichloroarsine (PD), lewisite (L), sulfur mustard (HD, H, HT, HL, HQ), nitrogen mustard (NH1, NH2, NH3), Tabun (GA), Sarin (GB), Soman (GD), Cyclosarin (GF), GV, Methyl fluorophosphoryl homocholine iodid (MFPhCh), EA-3148, VE, VG, VM, VP, VR, VX, Novichok agents, phoshene oxime (CX), chlorine, chloropicrin (PS), phosgene (CG), diphosgene (DP), disulfur decafluoride, agent 15 (BZ), dimethylheptylpyran (DMHP), EA-3167, kolokol-1, LSD-25, PAVA spray, sleeping gas, pepper spray (OC), CS, CN, CR, or combinations thereof.

4. The method of claim 3 , wherein the nerve agent comprises a gas phase, vapor phase, liquid phase, or an aerosol.

5. The method of claim 1 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (H 2 O) 6 (OH) 6 (O 2 ) 6 or Ti x Zr y Hf z (μ 3 -O) 8 (O 2 ) 6 and where the oxygen atoms from the organic linker are included in the formula.

6. The method of claim 1 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (O L ) 24 where x+y+z=6, m=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge.

7. The method of claim 1 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (OH) l X m (H 2 O) n (O L ) 16 where x+y+z=6, n=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge.

8. The method of claim 1 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (RCOO) 6 (O L ) 12 where x+y+z=6, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge.

9. The method of claim 1 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ3-OH) 4 (OH) l X m (H2O) n (O L ) 12 where x+y+z=6, m=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=6; where X is any anion with a −1 charge.

10. A metal-organic framework (MOF) comprising the coordination product of a metal ion and an at least bidentate organic ligand, wherein the metal ion and the organic ligand are selected to assemble a MOF configured to catalytically detoxify chemical warfare nerve agents wherein metal nodes of the MOF comprise derivatives of:
Ti x Zr y Hf z (μ 3 -O) r , where x+y+z=6 and r=4, 6 or 8,
wherein the metal nodes of the MOF comprise:
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (H 2 O) 6 (OH) 6 (O 2 ) 6 or Ti x Zr y Hf z (μ 3 -O) 8 (O 2 ) 6 and where the oxygen atoms from the organic linker are included in the formula and where x+y+z=6; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (O L ) 24 where x+y+z=6, m=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (OH) l X m (H 2 O) n (O L ) 16 where x+y+z=6, n=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (RCOO) 6 (O L ) 12 where x+v+z=6, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge; or
Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (OH) l X m (H 2 O) n (O L ) 12 where x+v+z=6, n=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=6; where X is any anion with a −1 charge.

11. The metal-organic framework of claim 10 , wherein the rate of catalytic detoxification comprises a measured catalytic half-life of no greater than 45 min measured at pH 10 with chemical warfare nerve agent concentration of 0.025 mol/L, containing 6 mol % of catalyst, and at 298 K.

12. The metal-organic framework of claim 10 , wherein the MOF acts as a catalyst to detoxify the chemical warfare nerve agents and acts as a sorbent that selectively adsorbs the chemical warfare nerve agents.

13. The metal-organic framework of claim 10 , wherein the MOF is a product of dehydration and contains unsaturated metal sites.

14. The metal-organic framework of claim 10 , wherein the metal cluster of the MOF ranges between and includes twelve-coordinate and three-coordinate.

15. The metal-organic framework of claim 10 , wherein the MOF has pore size diameters ranging from 4 to 55 Å.

16. The metal-organic framework of claim 10 , wherein the MOF has a BET measured surface area between 500 to 5000 m 2 /g.

17. The metal-organic framework of claim 10 , wherein the MOF is formed into a particle that has a size ranging from 100 nm to 5 mm.

18. The metal-organic framework of claim 10 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) 4 (H 2 O) 6 (OH) 6 (O 2 ) 6 or Ti x Zr y Hf z (μ 3 -O) 8 (O 2 ) 6 and where the oxygen atoms from the organic linker are included in the formula.

19. The metal-organic framework of claim 10 , wherein the metal nodes of the MOF comprise Ti x Zr y Hf z (μ 3 -O) 4 (μ 3 -OH) l X m (O L ) 24 where x+y+z=6, m=0-8, O L =any carboxylate oxygen atoms on a mono-, di-, tri-, or tetra-dentate ligand, and l+m=4; where X is any anion with a −1 charge.

20. The metal-organic framework of cl

Assignees

• Univ Northwestern

Inventors

• Hupp Joseph T
• Farha Omar K
• Katz Michael J
• Mondloch Joseph E

Classifications

• B01J35/1061

  Operations & Transport · mapped topic

• B01J2531/48

  Zirconium · CPC title

• B01D2257/93

  Toxic compounds not provided for in groups B01D2257/00 - B01D2257/708 · CPC title

• B01D2258/0225

  from chemical or biological warfare · CPC title

• A62B23/02

  for respirators · CPC title